Bausch Health Companies (BHC) Amortization of Deferred Charges (2009 - 2026)

Bausch Health Companies has disclosed Amortization of Deferred Charges across 18 years of filings, most recently posting $21.0 million for Q2 2026.

• In Q2 2026, Amortization of Deferred Charges fell 48.78% year-over-year to $21.0 million; the TTM figure through Jun 2026 stood at $73.0 million (down 12.05% YoY), while the FY2025 annual figure was $94.0 million, up 70.91% from the prior year.
• Amortization of Deferred Charges came in at $21.0 million for Q2 2026 at Bausch Health Companies, up from $14.0 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $50.0 million in Q2 2022 to a low of $11.0 million in Q1 2023.
• Average Amortization of Deferred Charges over 5 years is $19.3 million, with a median of $14.0 million recorded in 2022.
• Year-over-year, Amortization of Deferred Charges jumped 316.67% in 2022 and slumped 76.0% in 2023.
• Over 5 years, Amortization of Deferred Charges stood at $13.0 million in 2022, then grew by 7.69% to $14.0 million in 2023, then changed by 0.0% to $14.0 million in 2024, then surged by 57.14% to $22.0 million in 2025, then fell by 4.55% to $21.0 million in 2026.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $21.0 million in Q2 2026, $14.0 million in Q1 2026, and $22.0 million in Q4 2025.